Mama-Match
REMEVi review
A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Referral link, separate from the score
Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.
Gentler first steps than REMEVi
Providers we'd send a friend to, with the ones we work with listed first — CoreAge Rx leads our ranking on the score. Some of these links earn MamaGLP a referral commission.
- Meet CoreAge RxCoreAge RxOur #1 pick
The gentlest place to land if you're just starting out: one flat monthly price with no surprises, both medications in a single account, and an intake that walks you through it step by step instead of cornering you with a quiz.
- Meet Oak
An easy, fully asynchronous option in most states, with a low 'from' price and free delivery — just read the starting rates as a floor, since the real monthly price and the cancellation terms only come to light afterward.
- Meet Direct Meds
Injection or sublingual, both medications — but we list it only with the full story: a 2025 FDA warning letter and a pattern of BBB complaints about surprise 3-month charges make cancellation the real risk here.
REMEVi at a glance
- Semaglutide
- $149-219/mo depending on plan length
- Tirzepatide
- $199-319/mo depending on plan length
- Coverage
- All 50 states + DC
- Brand-name
- Compounded only
How we scored REMEVi
Each factor is judged from REMEVi's actual pricing, disclosures and support, then combined into the Mama-Match Score of 68/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
The start feels transactional — more cash register than welcome.
Fair pricing once you get past any teaser rate or plan structure.
Little public detail about who oversees your care, and how.
Wide coverage, though not confirmed in every state.
Support is thin once the prescription ships.
Cancelling carries real friction — commitments, notice windows or non-refundable charges.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- Medium
- Primary source
- remevihealth.com
Sourced from WLR's provider directory, independently re-verified live on remevihealth.com (2026-08-02) — both drugs' full three-tier pricing confirmed directly on their own pages. The oral-tablet option is real but its own separate price tier was not itemized on the pages checked; treated it as matching the injectable monthly rate pending a closer look.
What to expect when you sign up
We walked REMEVi's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.
- 1Each drug's own page shows a 'From $X/mo' headline, then a plan-length picker (Monthly / 12-Week / 52-Week) with real prices for each tier
- 2The page states '6 services · $400+/mo bought separately' are bundled into the number
- 3A bilingual (English/Spanish) support model is advertised, plus press mentions (AP, USA Today, Fortune, Reuters) and Google/Trustpilot ratings
What we noticed
- Genuinely transparent tiered pricing — all three plan lengths for both molecules are visible without starting an intake
- The site explicitly states the per-month price 'never climbs with your dose,' a real flat-pricing claim
- Licensed in all 50 states plus DC per its own claim; LegitScript and HIPAA badges displayed; cold-chain shipping every 4 weeks
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $219 | MonthlyPrice never climbs with dose. |
| Compounded semaglutide | $189 | 12-Week plan |
| Compounded semaglutide | $149 | 52-Week plan (best value)About $7.82/day on the monthly term equivalent, per the site's own framing. |
| Oral semaglutide | $219 | Daily tablet optionSame weekly-injection pricing structure offered as a daily oral tablet for needle-averse patients; exact oral tier pricing wasn't itemized separately on the page checked. |
| Compounded tirzepatide | $319 | Monthly |
| Compounded tirzepatide | $249 | 12-Week plan |
| Compounded tirzepatide | $199 | 52-Week plan (best value)Billed as $2,587 total, framed on-site as 'save $1,560' against the monthly rate. |
Swipe the table to see plan details →
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what REMEVi disclosed publicly at our last review and change often; confirm the current number on REMEVi's site.
What we like
- All three plan-length tiers for both molecules are visible on the public site, no intake required
- Explicitly states the price never climbs with dose — a real flat-pricing claim, not just a marketing line
- Bilingual (English/Spanish) support with WhatsApp, plus press mentions (AP, USA Today, Fortune, Reuters)
- Licensed in all 50 states plus DC; LegitScript and HIPAA badges displayed
The caveats
- No brand-name (FDA-approved) option
- The oral tablet option's own separate pricing tier wasn't itemized on the pages checked
- No published labs or follow-up cadence beyond the general '6 services bundled' claim
- Cheapest tier requires a 52-week upfront commitment to reach $149/mo (sema) or $199/mo (tirz); the monthly rate is meaningfully higher at $219/$319
REMEVi for moms: our verdict
A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized. It runs about $149/mo, flat across every dose.
We looked at REMEVi the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What REMEVi actually costs
- Compounded semaglutide — Monthly: $219/mo
- Compounded semaglutide — 12-Week plan: $189/mo
- Compounded semaglutide — 52-Week plan (best value): $149/mo
- Oral semaglutide — Daily tablet option: $219/mo
- Compounded tirzepatide — Monthly: $319/mo
- Compounded tirzepatide — 12-Week plan: $249/mo
That's roughly in line with our list's median of ~$157/mo.
The medications REMEVi prescribes
REMEVi prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss results, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better fit. These are compounded formulas from a licensed pharmacy — the reason the price stays low — but compounded GLP-1s are not FDA-approved finished products the way Wegovy and Zepbound are.
There's a needle-free oral or sublingual option on the menu, which appeals to moms who have been putting off injections — just set your expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions used in the trials.
Where REMEVi fits — and where it doesn't — for moms
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- you may need to switch between semaglutide and tirzepatide as your body and your hormones change.
- uninterrupted nationwide access matters to you — a move for the family shouldn't interrupt your care.
Look elsewhere if…
- you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
- you want friction-free cancellation — the fine print here is where the complaints cluster.
- you'd rather have a clinician talk the timing through with you, with the right timing around pregnancy and nursing in mind — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety and oversight
Our confidence is moderate — the core data holds up, but some details (state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
A standing caution for moms: GLP-1 medications are not proven safe during pregnancy or breastfeeding, and every label advises against use. None of this changes that — plan the timing with your own healthcare provider.
The bottom line
REMEVi is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For most moms, CoreAge Rx is still the best choice overall — see why it tops our ranking.
The bottom line
Best for: Moms who want to see every plan-length tier before committing and value bilingual (EN/ES) support.
Keep comparing REMEVi
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
REMEVi, answered
- How much does REMEVi cost?
- As of our last review, REMEVi's compounded pricing starts around $149/mo ($149-219/mo depending on plan length semaglutide, $199-319/mo depending on plan length tirzepatide). Confirm the current all-in price on REMEVi's site before you commit.
- Is REMEVi safe to use while breastfeeding?
- Here is the honest answer: no GLP-1 — compounded or brand-name — is established as safe during pregnancy or breastfeeding, and the labels advise against use; REMEVi is no exception. Plan any GLP-1 for after weaning, and talk the timing through with your own clinician.
- Does REMEVi offer both semaglutide and tirzepatide?
- Yes — REMEVi offers both. Tirzepatide's dual action is often preferred when insulin resistance is driving the weight, which matters with PCOS and after gestational diabetes.
- Where does REMEVi land in your ranking?
- REMEVi scores 68/100 on our Mama-Match Score (rank #26), which weights six things that matter to a first-timer. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Prices, states and verification reflect what REMEVi disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is gentle background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.